World Lifestyle Archives | Page 2 of 61 | Be Korea-savvy

Archive by category World Lifestyle

With OwlNest Blockchain Hotel Management Service, OwlTing Targets 30,000 Hospitality Clients by 2019

With OwlNest Blockchain Hotel Management Service, OwlTing Targets 30,000 Hospitality Clients by 2019

NEW YORK, Nov. 22 (Korea Bizwire) — The global travel & tourism industry is a US$7.6 trillion market, roughly 10% of the world’s GDP. Global brands and local hotel owners are facing fierce competition in the internet era. Over decades, hotels need to manage their own booking reservations from many channels and spend long hours [...]

VistaJet Partners With Christie’s for the Global Tour of The Collection of Peggy and David Rockefeller

VistaJet Partners With Christie’s for the Global Tour of The Collection of Peggy and David Rockefeller

LONDON, Nov. 22 (Korea Bizwire) — VistaJet, the first and only global private aviation company, announces today its worldwide sponsorship of the exhibition and tour of The Collection of Peggy and David Rockefeller, the most significant auction entirely dedicated to raising funds for philanthropic causes.  The sale, consisting of numerous categories, will be conducted by Christie’s, [...]

ITE: Hong Kong Citizens Spending Big on Travel

ITE: Hong Kong Citizens Spending Big on Travel

HONG KONG, CHINA, Nov. 22 (Korea Bizwire) – With total outbound spending of US$24.2 billion in 2016, Hong Kong ranked World’s 10th / Asia 3rd largest market (UNWTO Tourism Barometer Jun 17), but No.1 among these 10 largest markets by per capita spending of US$3285! Outbound to many Asian destinations continue growing! For examples, in [...]

Neuralstem Announces Presentation of Clinical Data for NSI-189 in Major Depressive Disorder at the Upcoming American College of Neuropsychopharmacology Annual Meeting

Neuralstem Announces Presentation of Clinical Data for NSI-189 in Major Depressive Disorder at the Upcoming American College of Neuropsychopharmacology Annual Meeting

GERMANTOWN, Md., Nov. 16 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that data from the Company’s Phase 2 study of NSI-189 in patients with major depressive disorder will be presented at the 56th American College of Neuropsychopharmacology (ACNP) Annual Meeting, which is being held [...]

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15 (Korea Bizwire) — Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targeted radiation” (MTR), has today listed on the Australian Securities Exchange (ASX) after raising $50 million in a fully underwritten Initial Public Offering [...]

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 13 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced the closing of its previously announced underwritten public offering of [...]

RedHill Biopharma Reports 2017 Third Quarter Financial Results

RedHill Biopharma Reports 2017 Third Quarter Financial Results

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 13 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today reported its financial results for the quarter ended September 30, 2017. [...]

Neuralstem Reports Third Quarter 2017 Fiscal Results and Provides Clinical and Business Update

Neuralstem Reports Third Quarter 2017 Fiscal Results and Provides Clinical and Business Update

GERMANTOWN, Md., Nov. 13 (Korea Bizwire) — Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, reported its financial results for the three and nine month periods ended September 30, 2017.             “We continue to evaluate the full Phase 2 data set for NSI-189 [...]

Vetter Expands its Footprint in Asia Pacific Region

Vetter Expands its Footprint in Asia Pacific Region

Songdo and Ravensburg, Nov. 10 (Korea Bizwire) - Vetter, one of the global leaders in prefilled drug-delivery systems, today announced the official opening of a new branch office in South Korea. The new office in Songdo is located within the biologics cluster which is often referred to as a ‘sweet spot’ by the industry as it houses numerous prominent [...]